Compounds
US6890923B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2002 |
| Grant date | May 10, 2005 |
| Priority date | — |
| Expiry date | Jan 9, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula or a pharmaceutically acceptable salt thereof, wherein R is —C(O)Ar1, —C(R4)(R5)Ar1 or Ar3; R3 represents a group X—R10 or Ar2; X represents a bond or a group NR11; and R10 represents C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl, each of which may be optionally substituted by one or more substituents independently selected from carboxyl, hydroxyl, —C(O)—R12, C3-6 cycloalkyl, morpholinyl, —NR13R14, —SR15, —OR16, phenyl and halophenyl, or R10 represents a C3-6 cycloalkylcarbonyl, —C(O)CH2CN, halophenylcarbonyl or trifluoromethylcarbonyl group. The compounds or compositions thereof are useful in the treatment or prophylaxis of autoimmune, inflammatory, proliferative and hyperproliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.